Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1034

1.

Classical NF-κB activation impairs skeletal muscle oxidative phenotype by reducing IKK-α expression.

Remels AH, Gosker HR, Langen RC, Polkey M, Sliwinski P, Galdiz J, van den Borst B, Pansters NA, Schols AM.

Biochim Biophys Acta. 2014 Feb;1842(2):175-85. doi: 10.1016/j.bbadis.2013.11.001. Epub 2013 Nov 8.

2.

Regulation of skeletal muscle oxidative phenotype by classical NF-κB signalling.

Remels AH, Gosker HR, Bakker J, Guttridge DC, Schols AM, Langen RC.

Biochim Biophys Acta. 2013 Aug;1832(8):1313-25. doi: 10.1016/j.bbadis.2013.03.018. Epub 2013 Apr 3.

3.

TNF-alpha impairs regulation of muscle oxidative phenotype: implications for cachexia?

Remels AH, Gosker HR, Schrauwen P, Hommelberg PP, Sliwinski P, Polkey M, Galdiz J, Wouters EF, Langen RC, Schols AM.

FASEB J. 2010 Dec;24(12):5052-62. doi: 10.1096/fj.09-150714. Epub 2010 Aug 31.

PMID:
20807714
4.

TNF-α-induced NF-κB activation stimulates skeletal muscle glycolytic metabolism through activation of HIF-1α.

Remels AH, Gosker HR, Verhees KJ, Langen RC, Schols AM.

Endocrinology. 2015 May;156(5):1770-81. doi: 10.1210/en.2014-1591. Epub 2015 Feb 24.

PMID:
25710281
5.

Activation of alternative NF-κB signaling during recovery of disuse-induced loss of muscle oxidative phenotype.

Remels AH, Pansters NA, Gosker HR, Schols AM, Langen RC.

Am J Physiol Endocrinol Metab. 2014 Mar;306(6):E615-26. doi: 10.1152/ajpendo.00452.2013. Epub 2014 Jan 14.

PMID:
24425759
6.

Loss of quadriceps muscle oxidative phenotype and decreased endurance in patients with mild-to-moderate COPD.

van den Borst B, Slot IG, Hellwig VA, Vosse BA, Kelders MC, Barreiro E, Schols AM, Gosker HR.

J Appl Physiol (1985). 2013 May;114(9):1319-28. doi: 10.1152/japplphysiol.00508.2012. Epub 2012 Jul 19.

PMID:
22815389
7.

Clematichinenoside inhibits VCAM-1 and ICAM-1 expression in TNF-α-treated endothelial cells via NADPH oxidase-dependent IκB kinase/NF-κB pathway.

Yan S, Zhang X, Zheng H, Hu D, Zhang Y, Guan Q, Liu L, Ding Q, Li Y.

Free Radic Biol Med. 2015 Jan;78:190-201. doi: 10.1016/j.freeradbiomed.2014.11.004. Epub 2014 Nov 13.

PMID:
25463279
8.

Tumor necrosis factor alpha triggers proliferation of adult neural stem cells via IKK/NF-kappaB signaling.

Widera D, Mikenberg I, Elvers M, Kaltschmidt C, Kaltschmidt B.

BMC Neurosci. 2006 Sep 20;7:64.

9.

Decreased exercise-induced expression of nuclear factor-κB-regulated genes in muscle of patients with COPD.

Mercken EM, Hageman GJ, Langen RC, Wouters EF, Schols AM.

Chest. 2011 Feb;139(2):337-346. doi: 10.1378/chest.10-0275. Epub 2010 Aug 5.

PMID:
20688919
10.

IKKα and alternative NF-κB regulate PGC-1β to promote oxidative muscle metabolism.

Bakkar N, Ladner K, Canan BD, Liyanarachchi S, Bal NC, Pant M, Periasamy M, Li Q, Janssen PM, Guttridge DC.

J Cell Biol. 2012 Feb 20;196(4):497-511. doi: 10.1083/jcb.201108118.

11.

Role of PKC-α in NF-κB-MT1-MMP-mediated activation of proMMP-2 by TNF-α in pulmonary artery smooth muscle cells.

Roy S, Chakraborti T, Chowdhury A, Chakraborti S.

J Biochem. 2013 Mar;153(3):289-302. doi: 10.1093/jb/mvs150. Epub 2012 Dec 24.

PMID:
23266860
12.

Minimal NF-κB activity in neurons.

Listwak SJ, Rathore P, Herkenham M.

Neuroscience. 2013 Oct 10;250:282-299. doi: 10.1016/j.neuroscience.2013.07.013. Epub 2013 Jul 17.

13.

siRNA-mediated reduction of inhibitor of nuclear factor-kappaB kinase prevents tumor necrosis factor-alpha-induced insulin resistance in human skeletal muscle.

Austin RL, Rune A, Bouzakri K, Zierath JR, Krook A.

Diabetes. 2008 Aug;57(8):2066-73. doi: 10.2337/db07-0763. Epub 2008 Apr 28.

14.

IRF-1 inhibits NF-κB activity, suppresses TRAF2 and cIAP1 and induces breast cancer cell specific growth inhibition.

Armstrong MJ, Stang MT, Liu Y, Yan J, Pizzoferrato E, Yim JH.

Cancer Biol Ther. 2015;16(7):1029-41. doi: 10.1080/15384047.2015.1046646.

15.

Ac-SDKP suppresses TNF-α-induced ICAM-1 expression in endothelial cells via inhibition of IκB kinase and NF-κB activation.

Zhu L, Yang XP, Janic B, Rhaleb NE, Harding P, Nakagawa P, Peterson EL, Carretero OA.

Am J Physiol Heart Circ Physiol. 2016 May 1;310(9):H1176-83. doi: 10.1152/ajpheart.00252.2015. Epub 2016 Mar 4.

16.

Counter-modulation of fatty acid-induced pro-inflammatory nuclear factor κB signalling in rat skeletal muscle cells by AMP-activated protein kinase.

Green CJ, Macrae K, Fogarty S, Hardie DG, Sakamoto K, Hundal HS.

Biochem J. 2011 Apr 15;435(2):463-74. doi: 10.1042/BJ20101517.

PMID:
21323644
17.
18.

[Effects of rosiglitazone on peroxisome proliferator activated receptor-γ pathway in patients with chronic obstructive pulmonary disease].

Zeng XL, Liu XJ, Bao HR, Zhang Y, Tan EL, Liao JM.

Zhonghua Jie He He Hu Xi Za Zhi. 2011 Oct;34(10):743-8. Chinese.

PMID:
22321707
19.

Peroxisome proliferator-activated receptor expression is reduced in skeletal muscle in COPD.

Remels AH, Schrauwen P, Broekhuizen R, Willems J, Kersten S, Gosker HR, Schols AM.

Eur Respir J. 2007 Aug;30(2):245-52. Epub 2007 Apr 25.

20.

Activation of NF-κB and respiratory burst following Aspergillus fumigatus stimulation of macrophages.

Sun H, Xu XY, Tian XL, Shao HT, Wu XD, Wang Q, Su X, Shi Y.

Immunobiology. 2014 Jan;219(1):25-36. doi: 10.1016/j.imbio.2013.06.013. Epub 2013 Jul 4.

PMID:
23886693

Supplemental Content

Support Center